Abstract
The author reviews the investigation and staging of patients with lung cancer. Surgical, radiotherapy, and chemotherapy roles in management of non-small cell lung cancer and small cell lung cancer are discussed. The author concludes with practical guidelines for screening and prevention by family physicians.
Keywords: family medicine, lung cancer, oncology
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Croog S. H., Richards N. P. Health beliefs and smoking patterns in heart patients and their wives: a longitudinal study. Am J Public Health. 1977 Oct;67(10):921–930. doi: 10.2105/ajph.67.10.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Devesa S. S., Blot W. J., Fraumeni J. F., Jr Declining lung cancer rates among young men and women in the United States: a cohort analysis. J Natl Cancer Inst. 1989 Oct 18;81(20):1568–1571. doi: 10.1093/jnci/81.20.1568. [DOI] [PubMed] [Google Scholar]
- Evans W. K., Feld R., Murray N., Willan A., Coy P., Osoba D., Shepherd F. A., Clark D. A., Levitt M., MacDonald A. Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med. 1987 Oct;107(4):451–458. doi: 10.7326/0003-4819-107-4-451. [DOI] [PubMed] [Google Scholar]
- Mountain C. F. A new international staging system for lung cancer. Chest. 1986 Apr;89(4 Suppl):225S–233S. doi: 10.1378/chest.89.4_supplement.225s. [DOI] [PubMed] [Google Scholar]
- Murray N., Shah A., Brown E., Kostashuk E., Laukkanen E., Goldie J., Band P., Van den Hoek J., Murphy K., Sparling T. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung. Semin Oncol. 1986 Sep;13(3 Suppl 3):24–30. [PubMed] [Google Scholar]
- Orleans C. T., George L. K., Houpt J. L., Brodie K. H. Health promotion in primary care: a survey of U.S. family practitioners. Prev Med. 1985 Sep;14(5):636–647. doi: 10.1016/0091-7435(85)90083-0. [DOI] [PubMed] [Google Scholar]
- Rapp E., Pater J. L., Willan A., Cormier Y., Murray N., Evans W. K., Hodson D. I., Clark D. A., Feld R., Arnold A. M. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. J Clin Oncol. 1988 Apr;6(4):633–641. doi: 10.1200/JCO.1988.6.4.633. [DOI] [PubMed] [Google Scholar]
- Simes R. J. Risk-benefit relationships in cancer clinical trials: the ECOG experience in non-small-cell lung cancer. J Clin Oncol. 1985 Apr;3(4):462–472. doi: 10.1200/JCO.1985.3.4.462. [DOI] [PubMed] [Google Scholar]
- Wilkins E. W., Jr, Scannell J. G., Craver J. G. Four decades of experience with resections for bronchogenic carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg. 1978 Sep;76(3):364–368. [PubMed] [Google Scholar]
- Wodinsky H. B., DeAngelis C., Rusthoven J. J., Kerr I. G., Sutherland D., Iscoe N., Buckman R., Kornijenko M. Re-evaluating the cost of outpatient cancer chemotherapy. CMAJ. 1987 Nov 15;137(10):903–906. [PMC free article] [PubMed] [Google Scholar]
- Wolf J., Patno M. E., Roswit B., D'Esopo N. Controlled study of survival of patients with clinically inoperable lung cancer treated with radiation therapy. Am J Med. 1966 Mar;40(3):360–367. doi: 10.1016/0002-9343(66)90131-8. [DOI] [PubMed] [Google Scholar]